SARS-CoV-2 vaccines have the potential to end the global pandemic of COVID-19; however, many challenges remain.
Data Evaluation and Learning for Viral Epidemics (DELVE), a multi-disciplinary group convened by the Royal Society, is releasing its latest report on the key challenges in developing, evaluating, manufacturing and distributing a vaccine for COVID-19, the impact of these challenges and future strategies to mitigate their effects.
Prof Charles Bangham, Chair of Immunology; Co-Director, Institute of Infection, Imperial College London
Dr Fiona Culley, National Heart and Lung Institute, Imperial College London
Prof Nilay Shah, Head of Department of Chemical Engineering, Imperial College London